Low-Grade Gliomas and Focal Cortical Developmental Malformations: Differentiation with Proton MR Spectroscopy

Radiology

Volumn 230, Issue 3, 2004, Pages 703-708

  Vuori, Kim ^a   Kankaanranta, Leena ^a   Häkkinen, Anna Maija ^a   Gaily, Eija ^b   Valanne, Leena ^a   Granström, Marja Liisa ^b   Joensuu, Heikki ^a   Blomstedt, Göran ^a   Paetau, Anders ^a   Lundbom, Nina ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Brain neoplasms; Diagnosis; Magnetic resonance (MR); MR; MR spectroscopy; Spectroscopy

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN CORTEX; BRAIN INJURY; BRAIN MALFORMATION; CANCER GRADING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; FOCAL CORTICAL DEVELOPMENTAL MALFORMATION; GLIOMA; HUMAN; HUMAN TISSUE; MALE; NEUROEPITHELIOMA; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; SEIZURE; STUDENT T TEST;

ADOLESCENT; ADULT; ASPARTIC ACID; ASTROCYTOMA; CEREBRAL CORTEX; CHILD; CHOLINE; CREATINE; DIAGNOSIS, DIFFERENTIAL; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROECTODERMAL TUMORS, PRIMITIVE; OLIGODENDROGLIOMA; PHOSPHOCREATINE; SENSITIVITY AND SPECIFICITY;

EID: 10744223019     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2303021804     Document Type: Article

References (25)

1. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990; 177:633-641.
2. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996; 84:449-458.
3. Meyerand ME, Pipes JM, Mamourian A, Tosteson TD, Dunn JF. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 1999; 20:117-123.
4. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001; 22:604-612.
5. S. Demaerel P, Johannik K, van Hecke P, et al. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991; 15:67-76.
6. Jones AP, Gunawardena WJ, Coutinho CM. 1H MR spectroscopy evidence for the varied nature of asymptotic focal brain lesions in neurofibromatosis type 1. Neuroradiology 2001; 43:62-67.
7. Castillo M, Green C, Kwock L, et al. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. AJNR Am J Neuroradiol 1995; 16:141-147.
8. Norfray JF, Darling C, Byrd S, et al. Short TE proton MRS and neurofibromatosis type 1 intracranial lesions. J Comput Assist Tomogr 1999; 23:994-1003.
9. Wilkinson ID, Griffiths PD, Wales JKH. Proton magnetic resonance of brain lesions in children with neurofibromatosis type 1. Magn Reson Imaging 2001; 19:1081-1089.
10. Li LM, Cendes F, Bastos AC, Andermann F, Dubeau F, Arnold DL. Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study. Neurology 1998; 50:755-759.
11. Lundbom N, Gaily E, Vuori K, et al. Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy. Epilepsia 2001; 42:1507-1514.
12. Giannini C, Scheithauer BW, Burger PC, et al. Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol 1999; 58:46-53.
13. Michaelis T, Merboldt KL, Bruhn H, Hänicke W, Frahm J. Absolute concentration of metabolites in the adult human brain in vivo: quantification of localized proton spectra. Radiology 1993; 187:219-227.
14. Kadota T, Horinouchi T, Kuroda C. Development and aging of the cerebrum: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2001; 22:128-135.
15. Angelie E, Bonmartin A, Boudraa A, Gonnaud PM, Mallet JJ, Sappey-Marinier D. Regional differerences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. AJNR Am J Neuroradiol 2001; 22:119-127.
16. Preul M, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996; 2:323-325.
17. Weber-Fahr W, Ende G, Braus DF, et al. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. Neuroimage 2002; 16:49-60.
18. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991; 4:47-52.
19. Urenjak J, Williams S, Gadian D, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13:981-989.
20. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989; 13: 23-31.
21. Baslow MH, Suckow R, Sapirstein V, Hungund BL. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Mol Neurosci 1999; 13:47-53.
22. Burger PC, Scheithauer BW. Tumors of the central nervous system. Washington, DC: Armed Forces Institute of Pathology; 1994.
23. Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995; 37: 476-487.
24. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000; 57:937-943.
25. Sartorius A, Neumann-Haefelin C, Vollmayr B, Hoehn M, Henn FA. Induction of choline rise in rat hippocampus by electroconvulsive shock treatment (abstr). In: Proceedings of the Tenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2002; 583.